CStone Pharmaceuticals
Na Wen has extensive work experience in clinical data management. They began their career as a Technical Supervisor at Pfizer China Global Data Service in 2007, where they worked until 2011. Na then joined AstraZeneca R&D as a Data Management Project Leader, a role they held for six years until 2017. Currently, Na is the Head of Clinical Data Management at CStone Pharmaceuticals, a position they have been in since 2017.
Na Wen holds a Master's Degree in Pharmacology from China Pharmaceutical University. Additionally, they obtained a certification in CCDM from SCDM in May 2011.
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.